Guided by our key cultural value of Courageous CaringTM and
driven by a sense of urgency, we are building an innovative
biopharma company that invests in, develops and
commercializes life-changing drug therapies.

See Our Advantage


Courageous Caring
in the Age of COVID
March 4, 2021

Throughout her career, Shao-Lee Lin, MD, PhD has always been driven by a personal mission to make a meaningful difference in patients’ lives.

ACELYRIN Launches with Funding
from Westlake Village BioPartners
December 15, 2020

Company founders Shao-Lee Lin, MD, PhD, and Bob Carey have proven track records of building multibillion-dollar medicines